# Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

> **NCT01961830** · PHASE1 · COMPLETED · sponsor: **Meiji Seika Pharma Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ME1100 inhalation solution

## Key facts

- **NCT ID:** NCT01961830
- **Lead sponsor:** Meiji Seika Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961830, "Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01961830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*